11.36
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$11.00
Aprire:
$11.17
Volume 24 ore:
6,939
Relative Volume:
0.66
Capitalizzazione di mercato:
$7.58M
Reddito:
-
Utile/perdita netta:
$-18.82M
Rapporto P/E:
-0.3642
EPS:
-31.1883
Flusso di cassa netto:
$-14.79M
1 W Prestazione:
+2.25%
1M Prestazione:
+10.61%
6M Prestazione:
-9.84%
1 anno Prestazione:
-92.49%
Envveno Medical Corp Stock (NVNO) Company Profile
Nome
Envveno Medical Corp
Settore
Industria
Telefono
949-261-2900
Indirizzo
70 DOPPLER, IRVINE
Compare NVNO vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
NVNO
Envveno Medical Corp
|
11.36 | 7.58M | 0 | -18.82M | -14.79M | -31.19 |
|
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Envveno Medical Corp Borsa (NVNO) Ultime notizie
NVNO Forecast — Price Target — Prediction for 2027 - TradingView
A42085 Forecast — Price Target — Prediction for 2027 - TradingView
enVVeno Medical receives U.S. patent for venous valve system By Investing.com - Investing.com Nigeria
enVVeno Medical receives U.S. patent for venous valve system - Investing.com
enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial - ACCESS Newswire
enVVeno patent covers key enVVe valve parts before pivotal FDA trial - Stock Titan
enVVeno Medical (NVNO) Gains 2.6% as Shares Test Key Resistance Near $11.67Ascending Triangle - dars.gov.et
Enterprise value to revenue forward of enVVeno Medical Corporation – NASDAQ:NVNO - TradingView
Price to sales forward of enVVeno Medical Corporation – NASDAQ:NVNO - TradingView
Price to sales forward of enVVeno Medical Corporation – FWB:5HJ0 - TradingView
Price to book forward of enVVeno Medical Corporation – NASDAQ:NVNO - TradingView
Price to earnings forward of enVVeno Medical Corporation – NASDAQ:NVNO - TradingView
Enterprise value to EBITDA forward of enVVeno Medical Corporation – NASDAQ:NVNO - TradingView
Price to book forward of enVVeno Medical Corporation – FWB:5HJ0 - TradingView
enVVeno Medical Corporation Actuals & Estimates (FWB:5HJ0) - TradingView
enVVeno Medical Corporation Actuals & Estimates (NASDAQ:NVNO) - TradingView
enVVeno Medical Corporation Actuals & Estimates (BOATS:NVNO) - TradingView
enVVeno Medical Corp (NVNO) Institutional Confidence - TradingKey
enVVeno Medical to Present in the Webull Corporate Connect Webinar Series - ACCESS Newswire
FDA-cleared venous valve study takes center stage at enVVeno webinar - Stock Titan
enVVeno Medical (NVNO) Dips 1.96%, Testing Support at $9.5Strong Buy Stocks - dars.gov.et
enVVeno Medical Corp (NVNO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
enVVeno Medical Corp (NVNO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
enVVeno Medical Corp (NVNO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
enVVeno Medical Corp (NVNO) Valuation: PE, PB & Fair Value Analysis - TradingKey
enVVeno Medical Corp (NVNO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
enVVeno Medical Corp (NVNO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
enVVeno Medical Corp (NVNO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
enVVeno Medical Corp (NVNO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
enVVeno Medical (NVNO) Retreats 1.96% as Stock Navigates Key Support at $9.50Value Stock Ideas - newsline.com
Insider Selling: Francis Duhay Sells Shares of enVVeno Medical C - GuruFocus
Director at enVVeno Medical (NASDAQ: NVNO) sells 140 shares under Rule 10b5-1 plan - Stock Titan
[144] enVVeno Medical Corp SEC Filing - Stock Titan
enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System - PhillyBurbs
enVVeno Medical Announces Reverse Stock Split - Great Falls Tribune
enVVeno Medical (NVNO) Holds Steady at $10.75 – Support and Resistance Define Neutral RangeUndervalued Stocks - newsline.com
enVVeno Medical to Participate in the Virtual Investor Closing Bell Series - ACCESS Newswire
EnVVeno Medical to Participate in the Virtual Investor Closing Bell Series - marketscreener.com
PMI Stock Price and Chart — AMEX:PMI - TradingView
NVNO Q3 2025 Earnings: Narrower-than-Expected Loss Drives Positive Stock ReactionMargin Expansion Trends - newsline.com
enVVeno Medical (NVNO) Edges Higher as Stock Tests Key Resistance Near $11.90Throwback Trade - The Legal Advocate
enVVeno Medical (NVNO) Edges Lower as Stock Holds Above Key SupportFRAMA Signal - newsline.com
enVVeno Medical (NVNO) Slips 1.03% as Price Hovers Near Key Support at $10.47Factor Crowding - newsline.com
NVNO Q3 2025 Earnings: Narrower Net Loss Surpasses Analyst ExpectationsEarnings Season Review - The Legal Advocate
This Tiny Medical-Device Stock Is Back Above $11. Its Next FDA Test Is the Whole Trade - Bez Kabli
NVNOenVVeno Medical Corp Stock Price and Quote - Finviz
enVVeno Medical Q3 2025 Earnings: Narrower Loss Beats Expectations as Clinical Programs AdvanceProfit Margin Analysis - The Legal Advocate
enVVeno Medical (NVNO) Q3 2025 Earnings: Narrower-Than-Expected Loss Signals Cost Discipline Progress - newsline.com
enVVeno Medical (NVNO) Edges Higher: Analyzing Recent Price Action and Key LevelsWave Truncation - Newser
Perceptive entities disclose 9.99% stake in enVVeno (NASDAQ: NVNO) - Stock Titan
This Medical Device Stock Just Plunged A Whopping 71% Today – Do You Own It? - MSN
Envveno Medical Corp Azioni (NVNO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):